Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Plastics Recycling EUPlastics Recycling EU
Not Confirmed
Not Confirmed
01-02 April, 2025
Not Confirmed
Not Confirmed
01-03 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Plastics Recycling EUPlastics Recycling EU
Industry Trade Show
Not Confirmed
01-02 April, 2025
Industry Trade Show
Not Confirmed
01-03 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
21 Dec 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/12/22/2800400/0/en/Polaris-Group-Announced-the-Acquisition-of-Genovior-Biotech-Initiating-Dual-Engine-Growth.html
04 Dec 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/12/04/2789883/0/en/Polaris-Group-Initiates-Phase-3-Trial-First-Patient-Successfully-Dosed-with-ADI-PEG-20-Placebo-plus-Gemcitabine-and-Docetaxel-for-Difficult-to-Treat-Leiomyosarcoma-LMS.html
29 Nov 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/11/30/2788176/0/en/Polaris-Group-Announces-First-Patient-Successfully-Dosed-with-ADI-PEG-20-Placebo-in-Phase-2a-Non-Alcoholic-Steatohepatitis-NASH-Study.html
16 Nov 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/11/17/2782330/0/en/Polaris-Group-Initiates-Rolling-Submission-of-Biologic-License-Application-BLA-for-ADI-PEG-20-with-U-S-FDA-to-Treat-Malignant-Pleural-Mesothelioma.html
ABOUT THIS PAGE